2 min read
RAPS US Convergence
Meet Veristat at RAPS US Convergence 2025
Where Regulatory Excellence Meets Real-World Impact
Veristat is delighted...
Veristat, a full-service CRO, can guide you through the planning and development process to help you successfully bring a new
myeloma cancer treatment to market. With 41% of our work in oncology trials and extensive experience with myeloma, Veristat can help advance your compound through the submission process. Our teams will collaborate to build the optimal program based upon the science of your product, while providing key functional services, including trial design, clinical monitoring, data management, medical writing and statistical consultation with regulatory representation.
|
Contact our team to learn more about our oncology experience, the work we have performed in the area of myeloma and how we can help you.
|
WORKING TOGETHER. The Veristat Oncology team:
Through application of cutting-edge research, novel trial designs, and innovative approaches, Veristat delivers excellence throughout every aspect of an oncology trial. |
2 min read
Sep 10, 2025 Veristat Events
Veristat is delighted...
5 min read
Aug 28, 2025 Veristat Events